Insider Holders & Insider Ownership - LEXICON PHARMACEUTICALS INC. (LXRX)

List of insiders holdings for LEXICON PHARMACEUTICALS INC.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
Invus Public Equities L.P.
Artal Treasury Ltd
Invus L.P.
Invus Public Equities Advisors LLC
Invus Advisors L.L.C.
Director
10% Owner		2024-12-09 21:33:20136,180,481
0		136,180,481Form 13D
Artal International S.C.A.
Wittouck Amaury
Artal International Management S.A.
Artal Group S.A.
Westend S.A.
Stichting Administratiekantoor Westend
Invus Public Equities L.P.
Invus L.P.
Invus Public Equities Advisors LLC
Invus Advisors L.L.C.
Director
10% Owner		2024-12-09 21:33:20136,180,481
0		136,180,481Form 13D
Artal Participations S.a r.l.
Director
10% Owner		2024-12-16 19:00:08136,180,481
0		136,180,481Form 3
Artal International S.C.A.
Minne Pascal
Artal International Management S.A.
Artal Group S.A.
Westend S.A.
Stichting Administratiekantoor Westend
Director
10% Owner		2020-12-17 14:43:180
71,178,364		71,178,364Form 4
Siren L.L.C.
Invus Global Management LLC
Director
10% Owner		2024-07-29 17:31:420
38,918,903		38,918,903Form 3
MCNAIR ROBERT C
10% Owner		2003-08-08 16:21:095,949,400
0		5,949,400Form 13D
Invus US Partners LLC
Ulys L.L.C.
DEBBANE RAYMOND
Director
10% Owner		2022-08-09 16:48:13331,545
5,451,204		5,782,749Form 4
Invus C.V.
Director
10% Owner		2021-01-05 21:21:124,321,214
0		4,321,214Form 4
Exton Michael
Chief Executive Officer		2025-02-18 16:16:423,774,480
0		3,774,480Form 4
SANDS ARTHUR T
President & CEO		2014-03-03 18:20:201,236,579
877,500		2,114,079Form 4
COATS LONNEL
Chief Executive Officer		2024-02-29 16:26:531,430,198
0		1,430,198Form 4
Coiante Scott M
SVP, Chief Financial Officer		2025-02-18 16:17:541,201,780
0		1,201,780Form 4
Corrigan Brian
SVP, Regulatory & QA		2025-02-18 16:18:381,121,660
0		1,121,660Form 4
MAIN ALAN J
EVP, Innov & Chem Sciences		2025-03-03 16:32:25508,494
0		508,494Form 4
Garner Thomas
SVP, Chief Commercial Officer		2024-02-12 16:14:04454,260
0		454,260Form 4
Crum Brian T
SVP, General Counsel & Secr.		2025-03-03 16:28:42433,045
0		433,045Form 4
ZAMBROWICZ BRIAN P
EVP, Chief Scientific Officer		2014-03-03 18:16:40402,953
0		402,953Form 4
WADE JEFFREY L
President and COO		2024-07-08 17:27:46307,000
0		307,000Form 4
Granowitz Craig B
SVP, Chief Medical Officer		2025-03-03 16:31:11304,495
0		304,495Form 4
Kassler-Taub Kenneth B.
SVP, Regulatory & QA		2024-02-29 16:29:48255,742
0		255,742Form 4
McDermott Wendy
SVP, Human Resources		2025-03-03 16:33:08253,976
0		253,976Form 4
BROWN PHILIP M
SVP, Clinical Development		2010-02-17 17:12:29253,606
0		253,606Form 4
BANSAL AJAY
EVP Corp Dev and CFO		2009-06-02 17:44:48250,000
0		250,000Form 4
TYLE PRAVEEN
EVP, R&D		2021-03-02 17:00:45204,771
0		204,771Form 4
RIGGS RANDALL B
SVP, Corp Licensing		2004-02-25 16:13:19192,500
0		192,500Form 4
Cheung Ivan
Director		2024-12-02 17:41:59186,685
0		186,685Form 4
GREGORY JULIA P
EVP and CFO		2008-02-11 18:05:27150,000
0		150,000Form 4
Alexander Kristen
VP, Finance and Accounting		2025-03-03 16:33:57132,068
0		132,068Form 4
Tessmer James F
VP, Finance & Accounting		2021-03-16 19:45:56122,746
0		122,746Form 4
Seth Kiernan
VP, Chief Commercial Officer		2023-03-01 16:55:29104,350
0		104,350Form 4
HOWSON TAMAR D
EVP of Bus Dev		2008-02-11 18:05:30100,000
0		100,000Form 4
Lapuerta Pablo
EVP and CMO		2020-04-24 17:02:5785,719
0		85,719Form 4
Tragash Steven Alan
VP, Corporate Affairs		2010-02-17 18:06:1785,500
0		85,500Form 4
LEFKOWITZ ROBERT J MD
Director		2024-05-13 16:03:0881,716
0		81,716Form 4
Swain Judith L
Director		2024-05-13 16:05:2681,716
0		81,716Form 4
Sullivan Diane E.
Director		2024-05-13 16:04:4181,716
0		81,716Form 4
SOBECKI CHRISTOPHER J
Director		2024-05-13 16:03:4881,716
0		81,716Form 4
DEBBANE RAYMOND
Director		2024-05-13 16:02:1981,716
0		81,716Form 4
BARKER SAM L
Director		2024-05-13 16:01:3281,716
0		81,716Form 4
Amouyal Philippe
Director		2024-05-13 16:00:4481,716
0		81,716Form 4
ISHIMOTO LANCE K
SVP, Intellectual Property		2008-02-11 18:05:3380,000
0		80,000Form 4
PERSON CHRISTOPHE
VP Informatics		2004-01-13 17:01:4875,900
0		75,900Form 4
DeFrancesco Lisa
SVP, IR and Corp Comm		2025-03-03 16:30:2464,924
0		64,924Form 4
SCHAFER CAROL
VP Finance - Communications		2003-12-10 15:01:4661,000
0		61,000Form 3
Santini Alexander A
EVP and CCO		2020-04-24 17:12:2255,584
0		55,584Form 4
PIGGOTT JAMES R PHD
SVP of Pharm Bio		2008-02-11 18:05:4050,000
0		50,000Form 4
NORTHCOTT JOHN
VP, Marketing, Comm Strategy		2015-03-03 16:08:1441,985
0		41,985Form 4
NIES ALAN S
Director		2023-05-22 16:05:2041,046
0		41,046Form 4
Palantoni Frank
Director		2023-05-22 16:06:0740,332
0		40,332Form 4
COLBERT WALTER F
SVP, HR and Corp Serv		2007-02-15 16:40:1340,000
0		40,000Form 4
ROSE CLAYTON STUART
Director		2007-06-27 16:34:1325,000
0		25,000Form 4
Mills Barry
Director		2007-04-27 16:35:3810,000
0		10,000Form 4
Wiltsey Kathleen M
Director		2009-04-27 16:40:2510,000
0		10,000Form 4
CLOHERTY PATRICIA M
Director		2006-04-28 17:58:2710,000
0		10,000Form 4
CASKEY C THOMAS
Director		2005-10-17 17:52:096,300
200		6,500Form 4